Ledger.Open graph →
SEC Form D · filed January 5, 2017

RaNA Therapeutics, Inc

Offering
$51.0M
Sold
$51.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Daniel Lynch · Cambridge, MADirectorRonald Renaud, Jr · Cambridge, MAExec · DirectorThomas Mccauley · Cambridge, MAExecOwen Hughes · Cambridge, MADirectorJean- Francois Formela · Cambridge, MADirectorBrian Gallagher · Dublin, IrelandDirectorOwen Hughes · Cambridge, MADirectorDaniel Lynch · Waltham, MADirectorJean- Francois Formela · Cambridge, MADirectorRonald Renaud, Jr · Cambridge, MAExec · DirectorBrian Gallagher · Simsbury, CTDirectorThomas Mccauley · Cambridge, MAExecOwen Hughes · Sudbury, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗